ImmunoPrecise Antibodies (STU:TQB) Days Sales Outstanding : 57.02 (As of Jan. 2025)

View and export this data going back to 2022. Start your Free Trial

What is ImmunoPrecise Antibodies Days Sales Outstanding?

ImmunoPrecise Antibodies's average Accounts Receivable for the three months ended in Jan. 2025 was €2.58 Mil. ImmunoPrecise Antibodies's Revenue for the three months ended in Jan. 2025 was €4.13 Mil. Hence, ImmunoPrecise Antibodies's Days Sales Outstanding for the three months ended in Jan. 2025 was 57.02.

The historical rank and industry rank for ImmunoPrecise Antibodies's Days Sales Outstanding or its related term are showing as below:

STU:TQB' s Days Sales Outstanding Range Over the Past 10 Years
Min: 30.11 Med: 52.5 Max: 69.45
Current: 52.19

During the past 13 years, ImmunoPrecise Antibodies's highest Days Sales Outstanding was 69.45. The lowest was 30.11. And the median was 52.50.

STU:TQB's Days Sales Outstanding is ranked better than
67.1% of 845 companies
in the Biotechnology industry
Industry Median: 70.81 vs STU:TQB: 52.19

ImmunoPrecise Antibodies's Days Sales Outstanding increased from Jan. 2024 (49.14) to Jan. 2025 (57.02).

ImmunoPrecise Antibodies Days Sales Outstanding Historical Data

The historical data trend for ImmunoPrecise Antibodies's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ImmunoPrecise Antibodies Days Sales Outstanding Chart

ImmunoPrecise Antibodies Annual Data

Trend

Dec14

Dec15

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Apr24

Days Sales Outstanding

Get a 7-Day Free Trial

52.88

53.97

48.16

52.63

52.19

ImmunoPrecise Antibodies Quarterly Data
	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
Days Sales Outstanding	Get a 7-Day Free Trial															49.14	48.37	55.06	49.41	57.02

Competitive Comparison of ImmunoPrecise Antibodies's Days Sales Outstanding

For the Biotechnology subindustry, ImmunoPrecise Antibodies's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ImmunoPrecise Antibodies's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ImmunoPrecise Antibodies's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where ImmunoPrecise Antibodies's Days Sales Outstanding falls into.

Save Embed

;

Save Embed

;

ImmunoPrecise Antibodies Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

ImmunoPrecise Antibodies's Days Sales Outstanding for the fiscal year that ended in Apr. 2024 is calculated as

	Days Sales Outstanding (A: Apr. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Apr. 2023 )	+	Accounts Receivable (A: Apr. 2024 ))	/	count )	/	Revenue (A: Apr. 2024 )	*	Days in Period
=	( (2.196	+	2.583)	/	2 )	/	16.711	*	365
=	2.3895					/	16.711	*	365
=	52.19

ImmunoPrecise Antibodies's Days Sales Outstanding for the quarter that ended in Jan. 2025 is calculated as:

	Days Sales Outstanding (Q: Jan. 2025 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Oct. 2024 )	+	Accounts Receivable (A: Jan. 2025 ))	/	count )	/	Revenue (A: Jan. 2025 )	*	Days in Period
=	( (2.739	+	2.421)	/	2 )	/	4.129	*	365 / 4
=	2.58					/	4.129	*	365 / 4
=	57.02

ImmunoPrecise Antibodies (STU:TQB) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

ImmunoPrecise Antibodies Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of ImmunoPrecise Antibodies's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

ImmunoPrecise Antibodies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmunoPrecise Antibodies Ltd (STU:TQB) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

IPA:USA

Address

Industrious 823 Congress Avenue, Suite 300, Austin, TX, USA, 78701

Website

https://www.ipatherapeutics.com

ImmunoPrecise Antibodies Ltd is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe.

ImmunoPrecise Antibodies Headlines

No Headlines